We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Healthcare Revolution Predicted with Rise of Genomic Testing for Personalized Medicine

By LabMedica International staff writers
Posted on 04 Mar 2015
Print article
A new Frost & Sullivan (Mountain View, CA, USA) analysis has found that the direct-to-individual sector of genomic testing is now thriving, though not without criticism about the potential medical interpretation of some forms of tests that may have been initially requested for nonmedical purposes, such as those for genealogy analysis.

For personalized medicine, the need to better understand an individual’s genetic information has risen. This emerging branch has given birth to companies providing tests to help understand genetic profiles and assess predisposition to inherited and other diseases. From new analysis, Frost & Sullivan reports in “Future of Genomic Testing” that with reduction in sequencing costs companies are providing affordable genetic tests directly to the individuals being tested, generally via e-commerce. However, the clinical accuracy of direct-to-consumer tests has come under scrutiny since single nucleotide polymorphism (SNP)-based sequencing is not as accurate as more expensive technology platforms such as whole exome or whole genome sequencing.

“Stringent protocols and standardization policies need to be put in place to separate medically-viable genetic tests from the ones catering to sheer curiosity,” said research analyst Madhumitha Rangesa, “The entire industry requires a gold standard approach that establishes a foundation for the development of advanced genetic tests.” Also, genetic information available to the public and stored infinitely in a virtual e-space will bring multiple safety and ethical implications. Apprehensions on potential segregation that could take place, especially by health or life insurance providers, cannot be ignored. And ownership rights of genetic information are not well-regulated, another cause for concern.

Genetic service companies must partner with or hire genetic counselors to clarify and explain test results to end-users in order to improve medical interventions, facilitate informed decisions, and raise awareness on legal issues. To ensure accuracy and credibility, small companies are collaborating with larger laboratories that have the necessary certifications and lab protocols.

“To further enhance genetic tests, several national initiatives that boost funding opportunities have been deployed,” added M. Rangesa, “Organizations like the National Institute of Health are heavily sponsoring academics and industrial research to encourage innovation in this rapidly-evolving landscape.”

The new report, part of the Technical Insights subscription, provides technology snapshots and trends in genomic testing as well as an impact assessment of key players and their pertinent business models. Following extensive interviews with market participants, Frost & Sullivan's expert analysts thoroughly examined whole exome, whole genome, SNP-based, and array-based sequencing.

Related Links:

Frost & Sullivan



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.